the short-term continuous treatment with propranolol and nadolol , a long-acting nonselective beta-adrenoblocker without own sympathomimetic activity , conducted in two randomized groups of men with stable arterial hypertension ( the diastolic ap greater than or equal to 95 mm hg ) has shown that by its hypotensive and negative chronotropic effects nadolol given in the mean dose 87 mg/day compared very favourably with propranolol administered in a dose of 144 mg/day .
C0020538
arterial hypertension
C0033497
propranolol